Innovations in clinical research improve public health by facilitating the discovery of treatments and increasing data about the effectiveness of new and existing treatments across different patient populations. We can work together to improve the clinical trial enterprise by leveraging existing data to plan high-quality clinical trials and enhance participant recruitment and retention through meaningful patient engagement. Integrating clinical trials with routine healthcare and widely sharing results can give health care providers and patients better access to research opportunities and the information they need to make evidence-based medical decisions. In CTTI’s 2030 vision for clinical trials:
- New medical products are available to care providers and patients more quickly and efficiently than today.
- Results of trials are broadly shared with participants and care providers, so they can be considered as part of the totality of evidence and acted upon for the benefit of the public’s health.
- With less expensive and more efficient clinical trials, more clinical trials and other types of research are done to answer the questions most important to patients.
Resources
Antibacterial Drug Development in a Time of Great Need: Global Expert Panel
On August 24, 2016, CTTI hosted a webinar on innovative approaches to transforming antibacterial drug development as recently featured in a Clinical Infectious Diseases (CID) supplement.
Recommendations for Streamlining Protocol Elements for HABP/VABP Trials
Recommendations for Streamlining Protocol Elements for Hospital-Acquired Bacterial Pneumonia (HABP/VABP)/Ventilator Associated Bacterial Pneumonia (VABP) Trials